Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1994;1(4):291–297. doi: 10.1155/MBD.1994.291a

Antitumor Organometallics. IV. The Mutagenic Potential of Some Diphenylantimony(III) Dithiophosphorus Derivatives

Carmen Socaciu 1, Ioan Pasca 1, Cristian Silvestru 2,✉, Adela Bara 3, Ionel Haiduc 2
PMCID: PMC2364908  PMID: 18476242

Abstract

Two diphenylantimony(III) derivatives of dithiophosphorus ligands, i.e. Ph2SbS2PPh2 and Ph2SbS2P(OPr-i)2, which were previously found to exhibit antitumor properties, have been now investigated for potential mutagenic effects in healthy and Ehrlich ascites tumor-bearing mice. Two short-term tests, i.e. the micronucleus test and the cytogenetic analysis, were used as end-points for mutagenicity. The results are consistent with a mutagenic potential for both organoantimony(III) compounds tested, the effect being higher for the phosphorodithioato derivative.

Full Text

The Full Text of this article is available as a PDF (759.8 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES